Multiple Myeloma Patients Face 1.80 Times Higher Heart Attack Risk

A recent Danish study reveals that multiple myeloma patients have the highest relative risk of myocardial infarction among cancer types.

A
Aapla Nagpur Desk
22 Nov 2026, 2:35 PM IST · 2 min read
Source: Emjreviews
Multiple Myeloma Patients Face 1.80 Times Higher Heart Attack Risk
KEY TAKEAWAYS
1

Multiple myeloma shows a 1.80 times higher risk of heart attacks compared to low-risk skin tumor patients.

2

One-year absolute myocardial infarction risk remains below 1% across all cancer types.

3

Competing mortality significantly influences cardiovascular risk assessments in cancer patients.

A nationwide study conducted in Denmark has found that patients diagnosed with multiple myeloma exhibit the highest relative risk of heart attacks among various cancer types. The research analyzed data from over 660,000 cancer patients, revealing significant disparities in the one-year risk of myocardial infarction (MI) across 13 different cancer subtypes. The findings underscore the necessity of considering specific cancer types and competing mortality when assessing cardiovascular outcomes following a cancer diagnosis.

The study, which spans from 2000 to 2023, focused on adults diagnosed with cancer, excluding those with prior histories of myocardial infarction or coronary revascularization. Researchers utilized patients with low-risk skin tumors as a reference group to compare outcomes across the different cancer subtypes. The results indicated that multiple myeloma patients faced a myocardial infarction risk 1.80 times greater than those in the reference group, with other cancers like bladder, kidney, leukemia, and gastrointestinal cancers also showing elevated risks.

Despite the heightened relative risks observed, the standardized one-year absolute risk of myocardial infarction remained below 1% for all cancer types. The estimates varied, with breast cancer patients at 0.31% and multiple myeloma patients at 0.91%. Bladder cancer had a risk of 0.86%, while kidney cancer was at 0.72%. This indicates that while relative risks may be significant, the actual incidence of heart attacks remains relatively low across the board.

The study also highlighted the impact of competing mortality on cardiovascular risk. The one-year all-cause mortality rates varied widely among cancer groups, ranging from 2.2% for patients with low-risk skin tumors to a staggering 71.9% for those with hepatobiliary and pancreatic cancers. The authors noted that this competing risk of death complicates the interpretation of early cardiovascular outcomes, suggesting that a lower incidence of myocardial infarction does not necessarily reflect a lower cardiovascular susceptibility in patients with high cancer mortality.

While the findings provide valuable insights into the early myocardial infarction risk among cancer populations, they do not establish causation between cancer subtype and heart attack risk. The observational nature of the study also means that detailed information on cancer treatment regimens and lifestyle factors was limited. The authors call for further research to explore the interactions between cancer prognosis, treatment exposure, and cardiovascular risk, emphasizing the importance for clinicians to consider both cardiovascular outcomes and cancer-related mortality when evaluating heart attack risk in cancer patients.

💬What did you think of this story?What did you think?

Read Next